Candel Therapeutics (CADL) Debt Ratio (2020 - 2023)
Historic Debt Ratio for Candel Therapeutics (CADL) over the last 4 years, with Q3 2023 value amounting to 0.41.
- Candel Therapeutics' Debt Ratio rose 7248.2% to 0.41 in Q3 2023 from the same period last year, while for Sep 2023 it was 0.41, marking a year-over-year increase of 7248.2%. This contributed to the annual value of 0.26 for FY2022, which is 404214.05% up from last year.
- According to the latest figures from Q3 2023, Candel Therapeutics' Debt Ratio is 0.41, which was up 7248.2% from 0.35 recorded in Q2 2023.
- In the past 5 years, Candel Therapeutics' Debt Ratio registered a high of 0.41 during Q3 2023, and its lowest value of 0.01 during Q4 2021.
- Its 4-year average for Debt Ratio is 0.22, with a median of 0.24 in 2022.
- As far as peak fluctuations go, Candel Therapeutics' Debt Ratio tumbled by 4809.46% in 2021, and later skyrocketed by 404214.05% in 2022.
- Candel Therapeutics' Debt Ratio (Quarter) stood at 0.01 in 2020, then crashed by 48.09% to 0.01 in 2021, then skyrocketed by 4042.14% to 0.26 in 2022, then surged by 57.01% to 0.41 in 2023.
- Its last three reported values are 0.41 in Q3 2023, 0.35 for Q2 2023, and 0.3 during Q1 2023.